This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E.v., Fraunhofer-Gesellschaft Zur Förderung Der Angewandten Forschung E.v., Tel Aviv University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: Marten Tobias Gerling: Innovator in Holography-Activated Cell Sorting
Introduction
Marten Tobias Gerling is a notable inventor based in Potsdam, Germany. He has made significant contributions to the field of cell sorting technology, particularly through his innovative patent that enhances the detection and analysis of cells.
Latest Patents
Gerling holds a patent for a "System and method thereof for real-time automatic label-free holography-activated sorting of cells." This invention relates to an automatic real-time technique that allows for label-free sorting of cells using holography. The method provides high discriminative power at the individual cell level, enabling rapid automated processing during cell visualization and flow. This technique has potential applications in cancer detection and in identifying various stages of oncogenesis.
Career Highlights
Throughout his career, Gerling has worked with prestigious institutions, including Tel Aviv University and Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. His work has focused on advancing technologies that improve cell analysis and sorting, which are crucial in medical research and diagnostics.
Collaborations
One of Gerling's notable collaborators is Itay Barnea. Their partnership has contributed to the development of innovative solutions in the field of cell sorting and analysis.
Conclusion
Marten Tobias Gerling's contributions to the field of holography-activated cell sorting demonstrate his commitment to advancing medical technology. His innovative patent and collaborations highlight the importance of research in improving cancer detection and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile